{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:57:39Z","timestamp":1791493059901,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01829-5","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:23:55Z","timestamp":1774081435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting of neuroinflammation, oxidative stress, and synaptic dysfunction by vinpocetine in alzheimer\u2019s disease: a comprehensive appraisal"],"prefix":"10.1007","volume":"41","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid S.","family":"Jabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayyadah F.","family":"Rafeeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan M.","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"1829_CR3","first-page":"253","volume":"4","author":"A Guyon","year":"2020","unstructured":"Guyon A, Rousseau J, B\u00e9gin F-G et al (2020) Base editing strategy allows insertion of the A673T mutation in APP gene to prevent the development of Alzheimer\u2019s disease. Mol Therapy-Nucleic Acids 4:24:253\u2013263","journal-title":"Mol Therapy-Nucleic Acids"},{"issue":"6","key":"1829_CR5","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s10787-025-01796-w","volume":"33","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Saad HM, Al-Gareeb AI, Albuhadily AK (2025) Targeting the JAK\/STAT3\/SOCS signaling pathway in Alzheimer\u2019s disease. Inflammopharmacology 33(6):2951\u20132962","journal-title":"Inflammopharmacology"},{"issue":"17","key":"1829_CR6","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.7150\/thno.118409","volume":"15","author":"BH Yoon","year":"2025","unstructured":"Yoon BH, Kim J, Sengupta S, Park CJ, Ko M, Kang JH, Ko YT, Kim Y, Lim SM, Bae Y, Choi M (2025) Targeted autophagic clearance of Tau protects against Alzheimer\u2019s disease through amelioration of Tau-mediated lysosomal stress. Theranostics 15(17):9240","journal-title":"Theranostics"},{"issue":"1","key":"1829_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s44400-025-00044-w","volume":"1","author":"ER Roy","year":"2025","unstructured":"Roy ER, Cao W (2025) Advancing Alzheimer\u2019s research by improving disease modeling of secondary tauopathy. npj Dement 1(1):38","journal-title":"npj Dement"},{"issue":"4","key":"1829_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/biomedicines7040097","volume":"9","author":"KG Yiannopoulou","year":"2019","unstructured":"Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou S (2019) Reasons for Failed trials of Disease-modifying Treatments for Alzheimer Disease and their Contribution in Recent Research. Biomedicines 9(4):97","journal-title":"Biomedicines"},{"key":"1829_CR9","doi-asserted-by":"publisher","unstructured":"Sheng J, Zhang S, Wu L et al (2022) Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer\u2019s disease. Front Aging Neurosci 14. https:\/\/doi.org\/10.3389\/fnagi.2022.1019187","DOI":"10.3389\/fnagi.2022.1019187"},{"issue":"6","key":"1829_CR11","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s11011-023-01254-y","volume":"38","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Alexiou A, Papadakis M, Elhussieny O, Saad HM, Batiha GE (2023) New insights on the potential effect of vinpocetine in Parkinson\u2019s disease: one of the neglected warden and baffling topics. Metab Brain Dis 38(6):1831\u20131840","journal-title":"Metab Brain Dis"},{"key":"1829_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.freeradbiomed.2022.11.022","volume":"193","author":"MR Tropea","year":"2022","unstructured":"Tropea MR, Gulisano W, Vacanti V et al (2022) Nitric oxide\/cGMP\/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer\u2019s disease. Free Radic Biol Med 193:657\u2013668. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.11.022","journal-title":"Free Radic Biol Med"},{"key":"1829_CR13","doi-asserted-by":"publisher","first-page":"1070677","DOI":"10.3389\/fphar.2022.1070677","volume":"13","author":"N Ahmad","year":"2022","unstructured":"Ahmad N, Lesa KN, Sudarmanto A, Fakhrudin N, Ikawati Z (2022) The role of Phosphodiesterase-1 and its natural product inhibitors in Alzheimer\u2019s disease: A review. Front Pharmacol 13:1070677","journal-title":"Front Pharmacol"},{"issue":"1","key":"1829_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/bc.bc_46_19","volume":"6","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Naji MT, Al-Mamorry F (2020) Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review. Brain Circulation 6(1):1\u20130","journal-title":"Brain Circulation"},{"issue":"3","key":"1829_CR15","first-page":"129","volume":"15","author":"H Al-Kuraishy","year":"2012","unstructured":"Al-Kuraishy H, Al-Windy S, Algareeb AI (2012) The Effects of Vinpocetine on the Psychomotor Performances: Randomized clinical trial, single blind random clinical study. Al-Nahrain J Sci 15(3):129\u2013133","journal-title":"Al-Nahrain J Sci"},{"key":"1829_CR16","doi-asserted-by":"publisher","first-page":"113768","DOI":"10.1016\/j.jconrel.2025.113768","volume":"382","author":"Z Ma","year":"2025","unstructured":"Ma Z, Liu X, Xie X, Fang Y, Jiang D, Zhao C, Li P, Fu Y, Ye L, Gao Y, Wu S (2025) Vinpocetine-mediated multidimensional active targeted delivery across the blood-brain barrier. J Controlled Release 382:113768","journal-title":"J Controlled Release"},{"issue":"1","key":"1829_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12028-022-01499-y","volume":"37","author":"PK Panda","year":"2022","unstructured":"Panda PK, Ramachandran A, Panda P, Sharawat IK (2022) Safety and efficacy of vinpocetine as a neuroprotective agent in acute ischemic stroke: a systematic review and meta-analysis. Neurocrit Care 37(1):314\u2013325","journal-title":"Neurocrit Care"},{"key":"1829_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2023.05.021","volume":"526","author":"B Hou","year":"2023","unstructured":"Hou B, Li D, Wang D et al (2023) Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway. Neuroscience 526:74\u201384. https:\/\/doi.org\/10.1016\/j.neuroscience.2023.05.021","journal-title":"Neuroscience"},{"key":"1829_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0361-9230(00)00354-3","volume":"53","author":"P B\u00f6n\u00f6czk","year":"2000","unstructured":"B\u00f6n\u00f6czk P, Guly\u00e1s B, Adam-Vizi V et al (2000) Role of sodium channel inhibition in neuroprotection: effect of vinpocetine. Brain Res Bull 53:245\u2013254. https:\/\/doi.org\/10.1016\/s0361-9230(00)00354-3","journal-title":"Brain Res Bull"},{"key":"1829_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fnins.2020.00223","volume":"14","author":"M Zhao","year":"2020","unstructured":"Zhao M, Hou S, Feng L, Shen P, Nan D, Zhang Y, Wang F, Ma D, Feng J (2020) Vinpocetine protects against cerebral ischemia-reperfusion injury by targeting astrocytic connexin43 via the PI3K\/AKT signaling pathway. Front NeuroSci 14:223","journal-title":"Front NeuroSci"},{"issue":"1","key":"1829_CR21","first-page":"324307","volume":"2014","author":"HM Alkuraishy","year":"2014","unstructured":"Alkuraishy HM, Al-Gareeb AI, Albuhadilly AK (2014) Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders\u2014a randomized controlled clinical study. Biomed Res Int 2014(1):324307","journal-title":"Biomed Res Int"},{"key":"1829_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12028-022-01499-y","volume":"37","author":"PK Panda","year":"2022","unstructured":"Panda PK, Ramachandran A, Panda P, Sharawat IK (2022) Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Neurocrit Care 37:314\u2013325. https:\/\/doi.org\/10.1007\/s12028-022-01499-y","journal-title":"Neurocrit Care"},{"key":"1829_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00210-018-1498-0","volume":"391","author":"RI Nadeem","year":"2018","unstructured":"Nadeem RI, Ahmed HI, El-Sayeh BM (2018) Protective effect of vinpocetine against neurotoxicity of manganese in adult male rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 391:729\u2013742. https:\/\/doi.org\/10.1007\/s00210-018-1498-0","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1829_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1567202612666150603130235","volume":"12","author":"S Gupta","year":"2015","unstructured":"Gupta S, Singh P, Sharma B, Sharma B (2015) Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia. CNR 12:240\u2013252. https:\/\/doi.org\/10.2174\/1567202612666150603130235","journal-title":"CNR"},{"key":"1829_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/324307","volume":"2014","author":"HM Alkuraishy","year":"2014","unstructured":"Alkuraishy HM, Al-Gareeb AI, Albuhadilly AK (2014) Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders\u2014A Randomized Controlled Clinical Study. Biomed Res Int 2014:1\u20138. https:\/\/doi.org\/10.1155\/2014\/324307","journal-title":"Biomed Res Int"},{"key":"1829_CR26","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s11011-018-0256-9","volume":"33","author":"IO Ishola","year":"2018","unstructured":"Ishola IO, Akinyede AA, Adeluwa TP, Micah C (2018) Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation. Metab Brain Dis 33:1493\u20131500. https:\/\/doi.org\/10.1007\/s11011-018-0256-9","journal-title":"Metab Brain Dis"},{"issue":"1","key":"1829_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12868-023-00790-8","volume":"24","author":"M Shekarian","year":"2023","unstructured":"Shekarian M, Salehi I, Raoufi S, Asadbegi M, Kourosh-Arami M, Komaki A (2023) Neuroprotective effects of vinpocetine, as a phosphodiesterase 1 inhibitor, on long-term potentiation in a rat model of Alzheimer\u2019s disease. BMC Neurosci 24(1):20","journal-title":"BMC Neurosci"},{"issue":"5","key":"1829_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/10715760000301041","volume":"33","author":"C Pereira","year":"2000","unstructured":"Pereira C, Agostinho P, Oliveira CR (2000) Vinpocetine attenuates the metabolic dysfunction induced by amyloid \u03b2-peptides in PC12 cells. Free Radic Res 33(5):497\u2013506","journal-title":"Free Radic Res"},{"issue":"3","key":"1829_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1567202612666150603130235","volume":"12","author":"S Gupta","year":"2015","unstructured":"Gupta S, Singh P, Mohan Sharma B, Sharma B (2015) Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia. Curr Neurovasc Res 12(3):240\u2013252","journal-title":"Curr Neurovasc Res"},{"key":"1829_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.lfs.2019.05.006","volume":"229","author":"AA Ali","year":"2019","unstructured":"Ali AA, Abo El-Ella DM, El-Emam SZ et al (2019) Physical & mental activities enhance the neuroprotective effect of vinpocetine & coenzyme Q10 combination against Alzheimer & bone remodeling in rats. Life Sci 229:21\u201335. https:\/\/doi.org\/10.1016\/j.lfs.2019.05.006","journal-title":"Life Sci"},{"issue":"1","key":"1829_CR32","first-page":"CD003119","volume":"2003","author":"S Szatm\u00e1ri","year":"2003","unstructured":"Szatm\u00e1ri S, Whitehouse P (2003) Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev 2003(1):CD003119","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1829_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1532-5415.1989.tb05682.x","volume":"37","author":"LJ Thal","year":"1989","unstructured":"Thal LJ, Salmon DP, Lasker B, Bower D, Klauber MR (1989) The safety and lack of efficacy of vinpocetine in Alzheimer\u2019s disease. J Am Geriatr Soc 37(6):515\u2013520","journal-title":"J Am Geriatr Soc"},{"key":"1829_CR34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4103\/2141-9248.139368","volume":"4","author":"A Ogunrin","year":"2014","unstructured":"Ogunrin A (2014) Effect of vinpocetine (cognitolTM) on cognitive performances of a nigerian population. Ann Med Health Sci Res 4:654. https:\/\/doi.org\/10.4103\/2141-9248.139368","journal-title":"Ann Med Health Sci Res"},{"key":"1829_CR35","doi-asserted-by":"publisher","unstructured":"Szatm\u00e1ri S, Whitehouse P (2003) Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev 2010. https:\/\/doi.org\/10.1002\/14651858.cd003119","DOI":"10.1002\/14651858.cd003119"},{"key":"1829_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/adr-200191","volume":"4","author":"O Sanders","year":"2020","unstructured":"Sanders O, Rajagopal L (2020) Phosphodiesterase Inhibitors for Alzheimer\u2019s Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale. J Alzheimer\u2019s Disease Rep 4:185\u2013215. https:\/\/doi.org\/10.3233\/adr-200191","journal-title":"J Alzheimer\u2019s Disease Rep"},{"issue":"2","key":"1829_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/ph16020151","volume":"16","author":"A Zag\u00f3rska","year":"2023","unstructured":"Zag\u00f3rska A, Czopek A, Fryc M, Jaromin A, Boyd BJ (2023) Drug discovery and development targeting dementia. Pharmaceuticals 16(2):151","journal-title":"Pharmaceuticals"},{"key":"1829_CR38","first-page":"115","volume":"65","author":"A Valikovics","year":"2012","unstructured":"Valikovics A, N\u00e9meth L, Cs\u00e1nyi A (2012) Study of the effects of vinpocetin on cognitive functions. Ideggy\u00f3gy\u00e1szati szemle 65:115\u2013120","journal-title":"Ideggy\u00f3gy\u00e1szati szemle"},{"issue":"1","key":"1829_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40659-022-00404-3","volume":"55","author":"C Novoa","year":"2022","unstructured":"Novoa C, Salazar P, Cisternas P, Gherardelli C, Vera-Salazar R, Zolezzi JM, Inestrosa NC (2022) Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define. Biol Res 55(1):39","journal-title":"Biol Res"},{"issue":"1","key":"1829_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12974-023-03003-5","volume":"21","author":"M Shi","year":"2024","unstructured":"Shi M, Chu F, Zhu F, Zhu J (2024) Peripheral blood amyloid-\u03b2 involved in the pathogenesis of Alzheimer\u2019s disease via impacting on peripheral innate immune cells. J Neuroinflamm 21(1):5","journal-title":"J Neuroinflamm"},{"issue":"7","key":"1829_CR41","doi-asserted-by":"publisher","first-page":"e14856","DOI":"10.1111\/cns.14856","volume":"30","author":"M AmeliMojarad","year":"2024","unstructured":"AmeliMojarad M, AmeliMojarad M (2024) The neuroinflammatory role of microglia in Alzheimer\u2019s disease and their associated therapeutic targets. CNS Neurosci Ther 30(7):e14856","journal-title":"CNS Neurosci Ther"},{"key":"1829_CR42","doi-asserted-by":"publisher","first-page":"110654","DOI":"10.1016\/j.intimp.2023.110654","volume":"122","author":"NE Elwany","year":"2023","unstructured":"Elwany NE, Abdelhamid AM, Mohamed NM, Khalil SS, Orabi EE, Abdelfattah AM (2023) Vinpocetine alleviates intestinal ischemia\/reperfusion injury and enhances M2 macrophage polarization in rats: Role of SIRT1\/SOCS3\/STAT3 signaling pathway. Int Immunopharmacol 122:110654","journal-title":"Int Immunopharmacol"},{"key":"1829_CR43","doi-asserted-by":"publisher","unstructured":"Zhou Q, Guo D, Li X et al (2020) Anti-inflammatory effects of vinpocetine in LPS-stimulated microglia via activation of AMPK. Acad Bras Ci\u00eanc 92. https:\/\/doi.org\/10.1590\/0001-3765202020200241","DOI":"10.1590\/0001-3765202020200241"},{"key":"1829_CR44","doi-asserted-by":"publisher","first-page":"1019187","DOI":"10.3389\/fnagi.2022.1019187","volume":"14","author":"J Sheng","year":"2022","unstructured":"Sheng J, Zhang S, Wu L, Kumar G, Liao Y, Gk P, Fan H (2022) Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer\u2019s disease. Front Aging Neurosci 14:1019187","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"1829_CR45","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3390\/ijms24033022","volume":"24","author":"J Tchekalarova","year":"2023","unstructured":"Tchekalarova J, Tzoneva R (2023) Oxidative stress and aging as risk factors for Alzheimer\u2019s disease and Parkinson\u2019s disease: the role of the antioxidant melatonin. Int J Mol Sci 24(3):3022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1829_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11033-023-09021-z","volume":"51","author":"R Dhapola","year":"2024","unstructured":"Dhapola R, Beura SK, Sharma P, Singh SK, HariKrishnaReddy D (2024) Oxidative stress in Alzheimer\u2019s disease: current knowledge of signaling pathways and therapeutics. Mol Biol Rep 51(1):48","journal-title":"Mol Biol Rep"},{"key":"1829_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20:148\u2013160. https:\/\/doi.org\/10.1038\/s41583-019-0132-6","journal-title":"Nat Rev Neurosci"},{"key":"1829_CR48","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R, Guo J, Ye X-Y et al (2022) Oxidative stress: The core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res Rev 77:101619. https:\/\/doi.org\/10.1016\/j.arr.2022.101619","journal-title":"Ageing Res Rev"},{"key":"1829_CR49","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/antiox8120608","volume":"8","author":"A Amato","year":"2019","unstructured":"Amato A, Terzo S, Mul\u00e8 F (2019) Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer\u2019s Disease. Antioxidants 8:608. https:\/\/doi.org\/10.3390\/antiox8120608","journal-title":"Antioxidants"},{"key":"1829_CR50","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00210-018-1498-0","volume":"391","author":"RI Nadeem","year":"2018","unstructured":"Nadeem RI, Ahmed HI, El-Sayeh BM (2018) Protective effect of vinpocetine against neurotoxicity of manganese in adult male rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 391:729\u2013742. https:\/\/doi.org\/10.1007\/s00210-018-1498-0","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"1","key":"1829_CR51","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13195-025-01869-6","volume":"17","author":"X Rong","year":"2025","unstructured":"Rong X, Yao X, Fang H, Saji J, Qian Y, Gu JX, Yang MY, Wei P, Liu CR, Chen B, Zhao PP (2025) Dual PDE4\/10A inhibition restores CREB1 function and enhances neuronal resilience in models of alzheimer\u2019s disease. Alzheimers Res Ther 17(1):231","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"1829_CR52","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.apsb.2022.09.023","volume":"13","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Le M, Yang Y, Wang W, Huang Y, Wang Q, Tian Y, Jiang M, Rao Y, Luo HB, Wu Y (2023) Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: Suppression of neuroinflammation by blocking NF-\u03baB transcription regulation and activating cAMP\/CREB axis. Acta Pharm Sinica B 13(3):1180\u20131191","journal-title":"Acta Pharm Sinica B"},{"key":"1829_CR53","doi-asserted-by":"publisher","first-page":"19066","DOI":"10.1074\/jbc.m710509200","volume":"283","author":"K Iijima-Ando","year":"2008","unstructured":"Iijima-Ando K, Hearn SA, Granger L et al (2008) Overexpression of Neprilysin Reduces Alzheimer Amyloid-\u03b242 (A\u03b242)-induced Neuron Loss and Intraneuronal A\u03b242 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death in Drosophila. J Biol Chem 283:19066\u201319076. https:\/\/doi.org\/10.1074\/jbc.m710509200","journal-title":"J Biol Chem"},{"issue":"1","key":"1829_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.21608\/rpbs.2024.301889.1309","volume":"8","author":"SM Atya","year":"2024","unstructured":"Atya SM (2024) cAMP\/PKA-CREB-BDNF Signaling Cascade and Phosphodiesterase 4 Inhibition: A Possible Neuroprotective Approach in Alzheimer\u2019s Disease. Records Pharm Biomedical Sci 8(1):158\u2013168","journal-title":"Records Pharm Biomedical Sci"},{"key":"1829_CR55","doi-asserted-by":"publisher","first-page":"115071","DOI":"10.1016\/j.bcp.2022.115071","volume":"201","author":"B Jyoti Dutta","year":"2022","unstructured":"Jyoti Dutta B, Singh S, Seksaria S et al (2022) Potential role of IP3\/Ca2\u2009+\u2009signaling and phosphodiesterases: Relevance to neurodegeneration in Alzheimer\u2019s disease and possible therapeutic strategies. Biochem Pharmacol 201:115071. https:\/\/doi.org\/10.1016\/j.bcp.2022.115071","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1829_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.55782\/ane-2022-004","volume":"82","author":"K Luhach","year":"2022","unstructured":"Luhach K, Kulkarni G, Singh V, Sharma B (2022) Vinpocetine ameliorates developmental hyperserotonemia induced behavioral and biochemical changes: role of neuronal function, inflammation, and oxidative stress. Acta Neurobiol Exp 82(1):35\u201351","journal-title":"Acta Neurobiol Exp"},{"issue":"6","key":"1829_CR57","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/00952990.2024.2361442","volume":"50","author":"M Olivares-Costa","year":"2024","unstructured":"Olivares-Costa M, Fabio MC, De la Fuente-Ortega E, Haeger PA, Pautassi R (2024) New therapeutics for the prevention or amelioration of fetal alcohol spectrum disorders: a narrative review of the preclinical literature. Am J Drug Alcohol Abus 50(6):749\u2013770","journal-title":"Am J Drug Alcohol Abus"},{"issue":"2","key":"1829_CR58","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/1673-5374.317957","volume":"17","author":"JD Panes","year":"2022","unstructured":"Panes JD, Wendt A, Ramirez-Molina O, Castro PA, Fuentealba J (2022) Deciphering the role of PGC-1\u03b1 in neurological disorders: from mitochondrial dysfunction to synaptic failure. Neural regeneration Res 17(2):237\u2013245","journal-title":"Neural regeneration Res"},{"issue":"3","key":"1829_CR59","first-page":"N","volume":"3","author":"ZQ Li","year":"2023","unstructured":"Li ZQ, Lin HS, Huang XP, Zhang SQ, Shu X, Wu XN (2023) Research progress on the role of PGC1\u03b1 in mitochondrial dysfunction associated with Alzheimer\u2019s disease. Ageing Neurodegenerative Dis 3(3):N\u2013A","journal-title":"Ageing Neurodegenerative Dis"},{"issue":"11","key":"1829_CR60","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.3390\/ijms22115769","volume":"22","author":"BC Mota","year":"2021","unstructured":"Mota BC, Sastre M (2021) The role of PGC1\u03b1 in Alzheimer\u2019s disease and therapeutic interventions. Int J Mol Sci 22(11):5769","journal-title":"Int J Mol Sci"},{"key":"1829_CR61","doi-asserted-by":"publisher","first-page":"108301","DOI":"10.1016\/j.fbio.2026.108301","volume":"13","author":"YL You","year":"2026","unstructured":"You YL, Byun HJ, Kang N, Lee MS, Lee JI, Park I, Choi HS (2026) Standardized olive pomace juice ameliorates scopolamine-induced cognitive decline in C57BL\/6 mice via AMPK\u03b1-SIRT1-PGC1\u03b1 and CREB-BDNF-TrkB signaling pathways. Food Bioscience 13:108301","journal-title":"Food Bioscience"},{"key":"1829_CR62","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.1073\/pnas.0401420101","volume":"101","author":"PJ Willy","year":"2004","unstructured":"Willy PJ, Murray IR, Qian J et al (2004) Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc Natl Acad Sci USA 101:8912\u20138917. https:\/\/doi.org\/10.1073\/pnas.0401420101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1829_CR63","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/med.22017","volume":"44","author":"Y Xiang","year":"2024","unstructured":"Xiang Y, Naik S, Zhao L, Shi J, Ke H (2024) Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases. Med Res Rev 44(4):1404\u20131445","journal-title":"Med Res Rev"},{"key":"1829_CR68","first-page":"102089","volume":"43","author":"S Tang","year":"2025","unstructured":"Tang S, Luo W, Cheng C, Shen L, Wu X, Xiao X (2025) BDNF gene therapy rescues neuronal function via unique and common transcriptional responses in A\u03b2 and tau-driven Alzheimer\u2019s disease mouse models. Biochem Biophys Rep 43:102089","journal-title":"Biochem Biophys Rep"},{"key":"1829_CR70","doi-asserted-by":"crossref","unstructured":"Abu-Elfotuh K, Tolba AM, Hussein FH, Hamdan AM, Rabeh MA, Alshahri SA, Ali AA, Mosaad SM, Mahmoud NA, Elsaeed MY, Abdelglil RM (2023) 70. Anti-alzheimer activity of combinations of cocoa with vinpocetine or other nutraceuticals in rat model: modulation of wnt3\/\u03b2-catenin\/GSK-3\u03b2\/nrf2\/HO-1 and PERK\/CHOP\/Bcl-2 pathways. Pharmaceutics. ;15(8):2063","DOI":"10.3390\/pharmaceutics15082063"},{"issue":"6","key":"1829_CR71","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s10787-022-01059-y","volume":"30","author":"K Bagri","year":"2022","unstructured":"Bagri K, Deshmukh R (2022) Vinpocetine restores cognitive and motor functions in Traumatic brain injury challenged rats. Inflammopharmacology 30(6):2243\u20132259","journal-title":"Inflammopharmacology"},{"issue":"9","key":"1829_CR72","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1007\/s12035-024-04003-z","volume":"61","author":"A Turkistani","year":"2024","unstructured":"Turkistani A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, Elfiky MM, Saad HM, Batiha GE (2024) Therapeutic potential effect of glycogen synthase kinase 3 beta (GSK-3\u03b2) inhibitors in Parkinson disease: exploring an overlooked avenue. Mol Neurobiol 61(9):7092\u20137108","journal-title":"Mol Neurobiol"},{"key":"1829_CR74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1172\/jci64516","volume":"123","author":"PTT Ly","year":"2012","unstructured":"Ly PTT, Wu Y, Zou H et al (2012) Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest 123:224\u2013235. https:\/\/doi.org\/10.1172\/jci64516","journal-title":"J Clin Invest"},{"key":"1829_CR75","doi-asserted-by":"publisher","first-page":"112516","DOI":"10.1016\/j.fct.2021.112516","volume":"156","author":"C-P Sun","year":"2021","unstructured":"Sun C-P, Zhang X-Y, Zhou J-J et al (2021) Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer\u2019s disease through GSK3\u03b2 signaling pathway. Food Chem Toxicol 156:112516. https:\/\/doi.org\/10.1016\/j.fct.2021.112516","journal-title":"Food Chem Toxicol"},{"key":"1829_CR76","doi-asserted-by":"publisher","unstructured":"Ji M, Niu S-Q, Mi H-Y et al (2023) Vinpocetine improves dyskinesia in Parkinson\u2019s disease rats by reducing oxidative stress and activating the Wnt\/\u03b2-catenin signaling pathway. Chem Biol Drug Des 103. https:\/\/doi.org\/10.1111\/cbdd.14358","DOI":"10.1111\/cbdd.14358"},{"issue":"1","key":"1829_CR77","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/ph14010061","volume":"14","author":"E Fedele","year":"2021","unstructured":"Fedele E, Ricciarelli R (2021) Memory enhancers for Alzheimer\u2019s dementia: focus on cGMP. Pharmaceuticals 14(1):61","journal-title":"Pharmaceuticals"},{"key":"1829_CR78","doi-asserted-by":"publisher","unstructured":"Fawzi SF, Mansour DE, Mansour P, George MY (2022) Phosphodiesterase Inhibitors: A Promising Avenue for Modulating Cognitive Dysfunction in Alzheimer\u2019s Disease. In Alzheimer\u2019s Disease (pp. 121\u2013134). CRC https:\/\/doi.org\/10.3389\/fnagi.2022.1019187","DOI":"10.3389\/fnagi.2022.1019187"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01829-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01829-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T10:02:00Z","timestamp":1774087320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01829-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1829"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01829-5","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}